EXO Therapeutics
Exo Therapeutics, Inc.
Boston, United States · $103.0M raised
- Headquarters
- Boston, Massachusetts
- Business Model
- B2B
- Website
- exo-therapeutics.com
- Total Funding
- $103.0M
- Last Round
- $78.0M Series BOct 2021
- Rounds
- 2
About
Biotech company developing ExoSight platform to discover novel enzyme-targeting therapeutics in oncology and inflammation.
Summary
EXO Therapeutics is a Biotech company based in Boston, United States. It has raised $103.0M in total across 2 rounds, most recently a $78.0M Series B round in Oct 2021. Investors include Newpath Management, Novartis Venture Fund and CRV (Charles River).
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...